Owners of original biomedicines are fighting tooth and nail to prevent biosimilar approvals, with patents being the principal battleground

The vaccine adds three more targets to a human vaccine candidate that showed promise

Penn researchers find blocking the activity of the ANGPTL3 protein strongly lowers triglycerides and cholesterol in pilot clinical trial

The findings, published online May 18 in the journal Cell, could lead to the first broadly effective ebolavirus therapies and vaccines

Companies are introducing column-free antibody labeling kits that can be used in place of traditional, labor-intensive column-based methods

With so many irreproducible results using antibodies across science, it is crucial to validate antibodies to ensure that they work for the lab’s application

Pre-clinical study from Penn demonstrates protection against HIV

Cell culture media fuel modern life sciences research. Whether the objective is cell-based assays, antibody production, or virus replication, the medium is a make-or-break component

The current Zika virus outbreak, which began in 2015 and is spread through mosquito bites and sexual intercourse, has been confirmed in 47 countries and has affected 1.3 billion people around the world

How a highly potent antibody that neutralizes Zika infection was discovered

Western blotting separates proteins by size and shape with an electric field applied to a gel, and then targeted proteins are stained with antibodies

Similar protection studies in primates are warranted, and if the findings hold up, ZIKV-177 could be developed as a protective antibody treatment for pregnant women at risk of Zika infection, the researchers concluded